SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 12.062
EU - Europa 4.649
AS - Asia 1.671
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 16
OC - Oceania 3
Totale 18.446
Nazione #
US - Stati Uniti d'America 12.037
PL - Polonia 984
SE - Svezia 932
UA - Ucraina 799
IT - Italia 735
CN - Cina 593
HK - Hong Kong 359
SG - Singapore 331
FI - Finlandia 304
TR - Turchia 292
DE - Germania 171
BG - Bulgaria 164
IE - Irlanda 157
GB - Regno Unito 139
FR - Francia 87
BE - Belgio 42
CA - Canada 25
CH - Svizzera 25
EU - Europa 20
RU - Federazione Russa 20
VN - Vietnam 18
NL - Olanda 17
BR - Brasile 16
IN - India 16
KR - Corea 14
HU - Ungheria 13
SN - Senegal 12
CZ - Repubblica Ceca 9
JP - Giappone 9
ES - Italia 8
IR - Iran 8
HR - Croazia 7
RO - Romania 7
GR - Grecia 6
ID - Indonesia 5
IQ - Iraq 5
MY - Malesia 5
PT - Portogallo 5
BD - Bangladesh 4
AT - Austria 3
CL - Cile 3
NO - Norvegia 3
PK - Pakistan 3
SI - Slovenia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AU - Australia 2
CO - Colombia 2
IL - Israele 2
LV - Lettonia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 18.446
Città #
Woodbridge 1.543
Fairfield 1.441
Ann Arbor 1.372
Houston 1.340
Warsaw 977
Chandler 935
Ashburn 850
Jacksonville 733
Wilmington 690
Seattle 626
Cambridge 482
Hong Kong 358
Princeton 308
Izmir 274
Trieste 261
Singapore 250
Beijing 177
Sofia 163
Dublin 157
Boardman 119
Dearborn 85
San Diego 71
Milan 70
Bremen 56
Santa Clara 52
Helsinki 51
Düsseldorf 43
Falls Church 43
Jinan 42
Brussels 40
Des Moines 36
Nanjing 31
Buffalo 27
Norwalk 26
Sacile 24
Chicago 23
Hefei 23
Washington 23
Verona 21
Bern 20
Dong Ket 18
Guangzhou 17
Kunming 17
Fremont 16
Denver 15
Mestre 15
Redwood City 15
Shenyang 15
Phoenix 14
Toronto 14
Shanghai 13
Dakar 12
Redmond 12
Dallas 11
Budapest 10
Gothenburg 10
Munich 10
Seoul 10
Columbus 9
Los Angeles 9
San Francisco 9
Auburn Hills 8
Brno 8
Edinburgh 8
Kocaeli 8
Port Coquitlam 8
São Paulo 8
Torre Del Greco 8
Fuzhou 7
Hebei 7
London 7
Moscow 7
Pune 7
Tulsa 7
Cascina 6
Detroit 6
Leawood 6
Nanchang 6
Philadelphia 6
Tappahannock 6
Tokyo 6
Zhengzhou 6
Andover 5
Boston 5
Changsha 5
Grafing 5
Hangzhou 5
Taizhou 5
Tianjin 5
Wolnzach 5
Wuhan 5
Zagreb 5
Amsterdam 4
Chengdu 4
Chongqing 4
Doncaster 4
Dongguan 4
Frankfurt Am Main 4
Hamburg 4
Indiana 4
Totale 14.362
Nome #
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 332
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 308
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 301
Rational design of antirheumatic prodrugs specific for sites of inflammation 295
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 229
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 216
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 212
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 210
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 202
Anti-transglutaminase antibodies and age. 194
Autoantibodies as predictors of disease. 191
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 189
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 182
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 182
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 180
The gut as site of production of autoimmune antibodies. 179
Anti transglutaminase antibodies cause ataxia in mice. 177
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 177
Recombinant antibody selections by combining phage and yeast display 177
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 175
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 175
Phage display technology for human monoclonal antibodies 167
null 166
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 165
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 163
null 163
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 161
Primer sets for cloning the human repertoire of T cell Receptor variable regions 159
A reliable screening procedure for coeliac disease in clinical practice. 157
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 154
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 152
Dual sugar gut-permeability testing on blood drop in animal models. 150
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 149
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 146
Development of a novel rapid non-invasive screening test for coeliac disease. 144
An Air-well sparging minifermenter system for high-throughput protein production 144
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 143
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 143
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 142
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 142
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 142
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 140
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 137
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 137
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 134
Gluten ataxia: passive transfer in a mouse model. 132
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 132
Antibodies in proteomics I: generating antibodies 131
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 131
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 131
A definitive set of oligonucleotide primers for amplifying human V regions 130
Plasmid incompatibility: More compatible than previously thought? 130
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 130
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 127
Anti-idiotypic response in mice expressing human autoantibodies. 127
Prevalence of celiac disease among risk groups and the general population in USA 127
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 126
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 126
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 125
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 124
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 124
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 124
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 123
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 123
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 120
null 119
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 118
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 118
Recombinant renewable polyclonal antibodies 117
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 117
A deep-blue OLED-based biochip for protein microarray fluorescence detection 116
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 115
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 114
Rapid and simple dot immunobinding assay to detect anti human transglutaminase antibodies in coeliac disease 114
null 114
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 113
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 112
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 112
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 111
Profiling celiac disease antibody repertoire 111
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 111
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice 111
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 110
Binders based on dimerised immunoglobulin VH domains 109
Antibodies to transglutaminasefrom phage display libraries 108
Mucosal tissue transglutaminase expression in celiac disease 108
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 107
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 106
Protective role of anti-idiotypic network in celiac disease prone subjects 106
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 102
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 101
null 100
Protective role of anti-idiotypic network in celiac disease prone subjects 100
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 99
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 99
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 98
Simple scale-up of recombinant antibody production using an UCOE containing vector 98
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 98
null 97
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 97
Totale 14.412
Categoria #
all - tutte 51.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.357 0 0 0 693 275 568 411 447 347 227 263 126
2020/20212.608 256 177 259 309 203 275 144 218 143 275 104 245
2021/20221.699 86 114 68 138 65 155 74 55 206 177 139 422
2022/20232.648 253 328 213 379 265 483 26 238 285 25 115 38
2023/20241.458 80 78 72 93 154 192 222 271 22 36 132 106
2024/2025504 40 159 256 49 0 0 0 0 0 0 0 0
Totale 18.938